Why ResMed's Rally Is Just Getting Started
ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD ...
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost ...
Impacts12d
Is CPAP Technology Becoming Obsolete? New Treatments Offer Hope in Sleep Apnea
A new survey shows that more than half of people diagnosed with obstructive sleep apnea (OSA) aren’t satisfied with their ...
Three stocks to note before the Fed rate cut decision
The stock market is trading slightly higher midday before the Fed releases its rate cut decision. The S&P 500 gained 0.12%, ...
India Sleep Apnea Devices Market is Forecast to Cross $223.5 Million by 2030: North India's Higher Level of Health Awareness is Driving Demand
The "India Sleep Apnea Devices Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added ...
The Globe and Mail24d
Stocks Close Higher as US Consumer Confidence Rises to 6-Month High
ResMed (RMD) closed up more than +7% to lead gainers in the S&P 500 after William Blair said the company views the GLP-1 weight loss drug impact as a “tailwind” for its sleep apnea and CPAP business.